Related Experiment Video
Updated: Jan 30, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Applied Informatics Decision Support Tool for Mortality Predictions in Patients With Cancer
Dimitris Bertsimas1, Jack Dunn1, Colin Pawlowski1
1Dimitris Bertsimas, Jack Dunn, Colin Pawlowski, John Silberholz, Alexander Weinstein, and Ying Daisy Zhuo, Massachusetts Institute of Technology, Cambridge; Eddy Chen, Massachusetts General Hospital Cancer Center; Harvard Medical School; Aymen A. Elfiky, Dana-Farber Cancer Institute; Brigham and Women's Hospital; Harvard Medical School, Boston, MA.
This study developed an interpretable machine learning tool to predict cancer patient mortality risk using electronic health records. The tool accurately identifies high-risk individuals, aiding clinical decision-making and personalized care.
Area of Science:
- Oncology
- Machine Learning
- Health Informatics
Background:
- Clinical decision-making in cancer treatment is complex due to evolving therapies and reliance on intuition for risk assessment.
- Accurate prognostication is crucial for effective cancer care but often lacks clear clinical rationale.
- There is a need for interpretable tools to identify patients at high risk of mortality before treatment initiation.
Purpose of the Study:
- To develop a highly interpretable prediction tool for identifying patients with high mortality risk.
- To provide a meaningful clinical rationale for prognostication in oncology.
- To aid oncologists in the complex decision-making process for cancer treatment regimens.
Main Methods:
- Utilized electronic health record data from 2004-2014, extracting 401 predictors.
- Developed an actionable machine learning tool to predict 60-, 90-, and 180-day mortality post-anticancer regimen.
- Validated the model in unseen data against benchmark models.
Main Results:
- Analyzed 23,983 patients initiating 46,646 treatment lines; median survival was 514 days.
- Achieved high estimation quality (AUC 0.83-0.86) in unseen data, outperforming benchmark models.
- Identified key mortality predictors including weight change and albumin levels; results are available via an interactive tool (www.oncomortality.com).
Conclusions:
- The transparent prediction model accurately distinguishes between high- and low-risk patients.
- Leverages electronic health record data and machine learning for precise prognostication.
- Potential to significantly impact value-based shared decision-making and personalized goals-of-care management in clinical practice.
Related Concept Videos
Self-Help Support Groups
Accessibility and Cost-Effectiveness
One of the primary strengths of self-help...
Predicting Molecular Geometry
Decision Making
Automatic decision-making is fast, intuitive, and relies on gut feelings...
Decision Making: P-value Method
First, a specific claim about the population parameter is proposed. The claim is based on the research question and is stated in a simple form. Further, an opposing statement to the claim is also stated. These statements can act as null and alternative hypotheses: a null hypothesis would be a neutral statement while the alternative hypothesis can...
Prediction Intervals
However, the point estimate is most likely not the exact value of the population parameter, but close to it. After calculating point estimates, we construct interval estimates, called confidence intervals or prediction intervals. This prediction interval comprises a range of values unlike the point estimate and is a better predictor of the observed sample value, y.
Support Reactions
The purpose of the supports is to prevent the translational motion of the system by applying an equal and opposite force and to prevent the system's rotation by applying...

